These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Yamada T; Sato S; Sotoyama Y; Orba Y; Sawa H; Yamauchi H; Sasaki M; Takaoka A Nat Immunol; 2021 Jul; 22(7):820-828. PubMed ID: 33976430 [TBL] [Abstract][Full Text] [Related]
47. Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus. Glanz A; Chakravarty S; Varghese M; Kottapalli A; Fan S; Chakravarti R; Chattopadhyay S Viruses; 2021 Mar; 13(4):. PubMed ID: 33805458 [TBL] [Abstract][Full Text] [Related]
48. Roles and functions of SARS-CoV-2 proteins in host immune evasion. Rashid F; Xie Z; Suleman M; Shah A; Khan S; Luo S Front Immunol; 2022; 13():940756. PubMed ID: 36003396 [TBL] [Abstract][Full Text] [Related]
49. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France. Quéromès G; Destras G; Bal A; Regue H; Burfin G; Brun S; Fanget R; Morfin F; Valette M; Trouillet-Assant S; Lina B; Frobert E; Josset L Emerg Microbes Infect; 2021 Dec; 10(1):167-177. PubMed ID: 33399033 [TBL] [Abstract][Full Text] [Related]
50. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses. Kehrer T; García-Sastre A; Miorin L J Interferon Cytokine Res; 2021 Jun; 41(6):205-219. PubMed ID: 34161170 [TBL] [Abstract][Full Text] [Related]
51. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19. Zhang J; Zhao C; Zhao W Front Immunol; 2021; 12():633769. PubMed ID: 33912161 [TBL] [Abstract][Full Text] [Related]
52. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Gusev E; Sarapultsev A; Solomatina L; Chereshnev V Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638 [TBL] [Abstract][Full Text] [Related]
53. SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction. Khatun O; Sharma M; Narayan R; Tripathi S Cell Mol Life Sci; 2023 Nov; 80(12):364. PubMed ID: 37982908 [TBL] [Abstract][Full Text] [Related]
56. The antiviral state of the cell: lessons from SARS-CoV-2. Le Pen J; Rice CM Curr Opin Immunol; 2024 Apr; 87():102426. PubMed ID: 38795501 [TBL] [Abstract][Full Text] [Related]
57. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV. Bouayad A Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714 [TBL] [Abstract][Full Text] [Related]
58. Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein. De Angelis M; Anichini G; Palamara AT; Nencioni L; Gori Savellini G Virol J; 2023 Oct; 20(1):239. PubMed ID: 37853388 [TBL] [Abstract][Full Text] [Related]
59. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness? Sacchi A; Giannessi F; Sabatini A; Percario ZA; Affabris E Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298304 [TBL] [Abstract][Full Text] [Related]
60. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2. Xia H; Shi PY J Interferon Cytokine Res; 2020 Dec; 40(12):543-548. PubMed ID: 33337934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]